Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis A new-user, active comparator design with instrumental variable analyses

Ryoji Tominaga, Tatsuyoshi Ikenoue, Ryosuke Ishii, Kakuya Niihata, Tetsuro Aita, Tadahisa Okuda, Sayaka Shimizu, Masataka Taguri, Noriaki Kurita
doi: https://doi.org/10.1101/2024.03.14.24304284

Article usage

Article usage: March 2024 to August 2025

AbstractFullPdf
Mar 20242541163
Apr 202475518
May 2024126865
Jun 202476745
Jul 202497559
Aug 2024801061
Sep 202454528
Oct 202433539
Nov 202443251
Dec 2024611027
Jan 2025961041
Feb 20251021952
Mar 2025504048
Apr 202566268
May 2025103875
Jun 2025431017
Jul 2025421625
Aug 2025110
Back to top
Posted March 15, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis A new-user, active comparator design with instrumental variable analyses
Ryoji Tominaga, Tatsuyoshi Ikenoue, Ryosuke Ishii, Kakuya Niihata, Tetsuro Aita, Tadahisa Okuda, Sayaka Shimizu, Masataka Taguri, Noriaki Kurita
medRxiv 2024.03.14.24304284; doi: https://doi.org/10.1101/2024.03.14.24304284
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area